NeoPharm (Korea) Price History
092730 Stock | KRW 12,000 90.00 0.74% |
If you're considering investing in NeoPharm Stock, it is important to understand the factors that can impact its price. As of today, the current price of NeoPharm stands at 12,000, as last reported on the 18th of December 2024, with the highest price reaching 12,030 and the lowest price hitting 11,790 during the day. At this point, NeoPharm is very steady. NeoPharm LTD has Sharpe Ratio of 0.0537, which conveys that the firm had a 0.0537% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for NeoPharm, which you can use to evaluate the volatility of the firm. Please verify NeoPharm's Downside Deviation of 2.78, mean deviation of 2.23, and Risk Adjusted Performance of 0.0591 to check out if the risk estimate we provide is consistent with the expected return of 0.15%.
NeoPharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NeoPharm |
Sharpe Ratio = 0.0537
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | 092730 | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.84 actual daily | 25 75% of assets are more volatile |
Expected Return
0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average NeoPharm is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeoPharm by adding it to a well-diversified portfolio.
NeoPharm Stock Price History Chart
There are several ways to analyze NeoPharm Stock price data. The simplest method is using a basic NeoPharm candlestick price chart, which shows NeoPharm price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 6, 2024 | 14620.0 |
Lowest Price | December 9, 2024 | 11090.0 |
NeoPharm December 18, 2024 Stock Price Synopsis
Various analyses of NeoPharm's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell NeoPharm Stock. It can be used to describe the percentage change in the price of NeoPharm from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of NeoPharm Stock.NeoPharm Market Facilitation Index | 0.01 | |
NeoPharm Accumulation Distribution | 807.84 | |
NeoPharm Price Rate Of Daily Change | 0.99 | |
NeoPharm Price Action Indicator | 45.00 | |
NeoPharm Price Daily Balance Of Power | (0.37) |
NeoPharm December 18, 2024 Stock Price Analysis
NeoPharm Stock Price History Data
The price series of NeoPharm for the period between Thu, Sep 19, 2024 and Wed, Dec 18, 2024 has a statistical range of 3870.0 with a coefficient of variation of 6.8. The prices are distributed with arithmetic mean of 12496.36. The median price for the last 90 days is 12500.0. The company had 1:2 stock split on 18th of September 2024.Open | High | Low | Close | Volume | ||
12/18/2024 | 12,000 | 12,030 | 11,790 | 12,000 | 40,493 | |
12/17/2024 | 12,010 | 12,160 | 11,910 | 12,000 | 28,832 | |
12/16/2024 | 12,140 | 12,280 | 11,950 | 12,090 | 55,398 | |
12/13/2024 | 11,940 | 12,060 | 11,770 | 11,950 | 41,243 | |
12/12/2024 | 11,880 | 12,200 | 11,850 | 11,940 | 33,407 | |
12/11/2024 | 11,590 | 12,050 | 11,230 | 11,850 | 51,583 | |
12/10/2024 | 11,130 | 11,710 | 11,110 | 11,590 | 49,729 | |
12/09/2024 | 11,310 | 11,430 | 11,000 | 11,090 | 130,138 | |
12/06/2024 | 11,880 | 11,880 | 11,390 | 11,600 | 88,698 | |
12/05/2024 | 11,860 | 12,000 | 11,600 | 11,890 | 66,639 | |
12/04/2024 | 11,800 | 12,160 | 11,300 | 12,000 | 53,686 | |
12/03/2024 | 11,730 | 12,390 | 11,730 | 12,040 | 74,606 | |
12/02/2024 | 11,980 | 12,050 | 11,650 | 11,730 | 49,156 | |
11/29/2024 | 12,280 | 12,280 | 11,310 | 12,100 | 53,440 | |
11/28/2024 | 12,210 | 12,460 | 12,180 | 12,280 | 55,216 | |
11/27/2024 | 12,270 | 12,880 | 12,100 | 12,400 | 139,907 | |
11/26/2024 | 12,000 | 12,400 | 11,810 | 12,400 | 88,518 | |
11/25/2024 | 11,580 | 12,040 | 11,440 | 12,000 | 145,589 | |
11/22/2024 | 11,650 | 11,990 | 11,360 | 11,580 | 167,049 | |
11/21/2024 | 12,000 | 12,000 | 11,710 | 11,840 | 32,758 | |
11/20/2024 | 12,160 | 12,160 | 11,790 | 11,840 | 100,463 | |
11/19/2024 | 12,880 | 12,890 | 12,360 | 12,370 | 55,505 | |
11/18/2024 | 12,940 | 13,270 | 12,600 | 12,890 | 33,164 | |
11/15/2024 | 13,120 | 13,480 | 12,820 | 13,070 | 19,054 | |
11/14/2024 | 12,960 | 13,200 | 12,800 | 13,010 | 36,047 | |
11/13/2024 | 12,520 | 13,040 | 12,360 | 13,020 | 70,973 | |
11/12/2024 | 13,570 | 13,900 | 12,690 | 12,850 | 69,615 | |
11/11/2024 | 14,380 | 14,380 | 13,510 | 13,570 | 41,211 | |
11/08/2024 | 14,110 | 14,400 | 14,050 | 14,050 | 36,783 | |
11/07/2024 | 14,710 | 14,930 | 13,960 | 14,100 | 143,587 | |
11/06/2024 | 14,230 | 14,850 | 14,100 | 14,620 | 145,956 | |
11/05/2024 | 14,360 | 14,430 | 13,900 | 14,230 | 64,355 | |
11/04/2024 | 13,730 | 15,100 | 13,700 | 14,150 | 269,008 | |
11/01/2024 | 12,920 | 13,410 | 12,510 | 13,200 | 64,267 | |
10/31/2024 | 13,400 | 13,400 | 12,830 | 12,920 | 59,582 | |
10/30/2024 | 13,570 | 13,850 | 13,010 | 13,400 | 112,652 | |
10/29/2024 | 13,375 | 13,400 | 12,950 | 13,250 | 229,638 | |
10/28/2024 | 13,300 | 13,550 | 13,100 | 13,400 | 160,180 | |
10/25/2024 | 13,750 | 13,850 | 13,300 | 13,450 | 150,874 | |
10/24/2024 | 13,350 | 13,750 | 13,150 | 13,675 | 175,206 | |
10/23/2024 | 13,000 | 13,425 | 12,650 | 13,350 | 215,782 | |
10/22/2024 | 12,625 | 13,100 | 12,425 | 12,875 | 107,488 | |
10/21/2024 | 12,650 | 12,925 | 12,525 | 12,750 | 68,778 | |
10/18/2024 | 13,175 | 13,175 | 12,500 | 12,600 | 105,934 | |
10/17/2024 | 13,225 | 13,325 | 12,675 | 12,950 | 154,096 | |
10/16/2024 | 13,375 | 13,850 | 13,050 | 13,150 | 517,502 | |
10/15/2024 | 12,750 | 12,850 | 12,400 | 12,825 | 51,374 | |
10/14/2024 | 12,400 | 12,625 | 12,300 | 12,500 | 52,504 | |
10/11/2024 | 12,775 | 12,775 | 12,300 | 12,500 | 79,156 | |
10/10/2024 | 12,250 | 12,850 | 12,250 | 12,650 | 107,570 | |
10/08/2024 | 12,800 | 12,800 | 12,225 | 12,225 | 66,420 | |
10/07/2024 | 12,850 | 12,950 | 12,300 | 12,800 | 99,850 | |
10/04/2024 | 12,600 | 12,825 | 12,000 | 12,650 | 181,844 | |
10/02/2024 | 13,100 | 13,475 | 12,350 | 12,600 | 216,232 | |
09/30/2024 | 13,175 | 13,825 | 12,975 | 13,200 | 253,466 | |
09/27/2024 | 12,350 | 13,325 | 12,325 | 13,175 | 333,668 | |
09/26/2024 | 11,525 | 12,475 | 11,475 | 12,475 | 255,324 | |
09/25/2024 | 11,350 | 11,925 | 11,250 | 11,550 | 134,888 | |
09/24/2024 | 11,475 | 11,500 | 11,200 | 11,250 | 45,186 | |
09/23/2024 | 11,275 | 11,450 | 11,100 | 11,450 | 53,036 | |
09/20/2024 | 11,225 | 11,500 | 11,125 | 11,275 | 96,180 |
About NeoPharm Stock history
NeoPharm investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeoPharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeoPharm LTD will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeoPharm stock prices may prove useful in developing a viable investing in NeoPharm
,Ltd. manufactures and sells skin care products in Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Daejeon, South Korea. Neopharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
NeoPharm Stock Technical Analysis
NeoPharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
All Next | Launch Module |
NeoPharm Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NeoPharm's price direction in advance. Along with the technical and fundamental analysis of NeoPharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeoPharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0591 | |||
Jensen Alpha | 0.2194 | |||
Total Risk Alpha | (0.03) | |||
Sortino Ratio | 0.0506 | |||
Treynor Ratio | (0.55) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for NeoPharm Stock analysis
When running NeoPharm's price analysis, check to measure NeoPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeoPharm is operating at the current time. Most of NeoPharm's value examination focuses on studying past and present price action to predict the probability of NeoPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeoPharm's price. Additionally, you may evaluate how the addition of NeoPharm to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements |